Arthur A. Levin, Chief Scientific Officer at Avidity Biosciences, Inc. (RNA), sold 10,000 shares at $22.00 ($220K) on 2023-01-12, disclosed to the SEC on 2023-01-17.
Open-market sale of $220k RNA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RNA | SELL | 2025-08-08 | $5.1M | — | Filing → |
| RNA | SELL | 2025-01-23 | $107K | — | Filing → |
| RNA | SELL | 2024-11-20 | $280K | — | Filing → |